⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Society for Science selects 100 educators for the 2026–2027 Advocate Program, investing $326,000 to expand student access to scientific research and science competitions
globenewswire.com
REGN
TMO
The Galien Foundation Announces 2026 International Prix Galien Award Nominees
prnewswire.com
AZN
MRK
BMY
GILD
JNJ
PFE
REGN
VRTX
MED
BFLY
EW
NVCR
NVO
IMCR
Levi & Korsinsky Urges Regeneron Pharmaceuticals, Inc. (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP
prnewswire.com
REGN
Generic Injectables Market Research Report 2026 - Revenue to Reach $285.61 Billion by 2031, Driven by Patent Expirations and Biosimilar Growth
globenewswire.com
PFE
BIIB
AMGN
REGN
BMY
GILD
ABBV
MRK
JNJ
BAX
VTRS
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 – Contact Levi & Korsinsky
accessnewswire.com
REGN
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
globenewswire.com
REGN